Business Description
Enveric Biosciences is a Cambridge, Massachusetts-based company founded in 2020 that researches and develops new medicines targeting mental health conditions such as anxiety, depression, and addiction. Its pipeline includes two early-stage compounds ? EB-002, derived from psilocybin, and EB-003 ? both being studied for their potential to treat anxiety and broader mental health challenges. The company is also exploring specialized cannabis-based molecules as possible treatments for pain and cancer.
